At Gilead Sciences' 2026 annual meeting, the company faced a shareholder proposal from David Bahnsen, founder of The Bahnsen Group over the use of ESG and DEI metrics in executive compensation. Listen to David's presentation, urging the company to prioritize executive clarity and business performance over activist incentives. "Gilead does not need to be grabbing headlines or seeking activist plaudits over inclusion initiatives. Its core business, meeting the needs of humanity by combatting the world’s deadliest diseases, is a noble, commendable, and lifesaving model that every investor can and ought to be proud of. Gilead has done it so very well." Learn more about The Bahnsen Group at thebahnsengroup.com.See omnystudio.com/listener for privacy information.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Meeting of Minds Podcast
Detransitioner Soren Aldaco at Amex: Take Transition Coverage Risk Seriously
Inspire Investing: Docusign, Don't Sign off on Non-Fiduciary Executive Pay
The Heritage Foundation: Drop Politicization at S&P Global
David Bahnsen: Cummins, Power America - Not Activism
Get summaries like this every morning.
Free AI-powered recaps of Meeting of Minds Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.